New patent on Hexvix granted in US
07-Nov-2007
President and CEO, Kjetil Hestdal says in a comment: "We are very pleased to see this result of our continuous commitment to strengthen our intellectual property of existing and new products. This broadening and extension of current patent protection of Hexvix in US is a major contribution to secure the success of Hexvix."
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.